BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
search help

Documents 1-25 out of over 974 found
  Current Search:  efavirenz: 1470  

100%
HTML
IFPMA News: In the Media
The Tech Central Station 20 April 2004 Merck Grants South Africa License for Generic Efavirenz Reuters 20 April 2004 Merck Gives SA Firm Rights to Key AIDS Drug AllAfrica 20 April 2004 Price of AIDS Drug Intensifies Debate on Legal Imports The New York Times 20 April 2004 Medicare Web Site to Shine Light on Drug Prices The New York Times 20 April 2004 Drug Makers Hope to Kill...
Matching: efavirenz Find similar documents More document info
100%
HTML
Annual Report 2004 - Medicines and vaccines
Arcoxia® (etoricoxib) Osteoarthritis Rheumatoid arthritis (adult) Acute pain Chronic low back pain Dysmenorrhea (menstrual pain) Acute gouty arthritis Cancidas® (caspofungin acetate) Empiric therapy for presumed fungal infections in febrile, neutropenic patients Treatment of invasive aspergillosis in patients who did not respond to or were intolerant of other antifungal...
Matching: efavirenz Find similar documents More document info
100%
HTML
Merck News Item
The left navigation bar requires Javascript to be enabled.
MK-0518, developed by Merck & Co., Inc., Whitehouse Station, New Jersey, USA, could be the first in a new class of investigational anti-retroviral therapy (ART) called integrase inhibitors that may inhibit the integrase enzyme from inserting HIV viral DNA into the human gene*.A- Inhibiting integrase from performing this...
Matching: efavirenz Find similar documents More document info
100%
HTML
http://www.merck.com/finance/annualreport/ar2003/product_review/
Annual Report 2003 Chairman's message Financial highlights Management Product review Research pipeline Selected licensing agreements Financial section Board of Directors Corporate information - Merck's commitment: novel medicines that make a difference click photos Product review 1.prtitle { font-size : 12px; padding-left : 9px; padding-right : 2px; padding-bottom : 12px; width:...
Matching: efavirenz Find similar documents More document info
100%
HTML
Human Immunodeficiency Virus Infection: Merck Manual Home Edition
Drugs For HIV Infection Type Drug Side Effects Non-nucleoside reverse transcriptase inhibitors - Delavirdine Rash, headaches - Efavirenz Dizziness, sleepiness, nightmares, confusion, agitation, forgetfulness, euphoria, rash - Nevirapine Rash (occasionally severe or life threatening), liver dysfunction Nucleoside and nucleotide reverse transcriptase inhibitors - - All may cause...
Matching: efavirenz Find similar documents More document info
100%
HTML
Index: EF: Merck Manual Home Edition
Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Matching: efavirenz Find similar documents More document info
100%
HTML
Merck News Item
Grants License for HIV/AIDS Drug Efavirenz to South African Company, Thembalami Pharmaceuticals, in Effort to Accelerate Access to Life-Saving Treatment - WHITEHOUSE STATION, N.J., July-13,-2004 - Merck & Co., Inc., (the parent company of MSD (Pty) Ltd.
Efavirenz is a non-nucleoside reverse transcriptase inhibitor used in combination therapy for the treatment of HIV...
Matching: efavirenz Find similar documents More document info
100%
HTML
Merck News Item
The left navigation bar requires Javascript to be enabled.
Overall favorable response rates showed CANCIDAS to be as effective as AmBisome with 33.9 percent and 33.7 percent of patients meeting all five criteria in each group, respectively.A- Favorable response rates for CANCIDAS and AmBisome on each of the following strictly defined components of the primary endpoint were:...
Matching: efavirenz Find similar documents More document info
100%
HTML
Merck News Item
The left navigation bar requires Javascript to be enabled.
Conference Call and Audio Web Cast - 31-Oct-2005- Merck and Bristol-Myers Squibb License New AIDS Drugs to IPM for Development as Microbicides to Protect Women from HIV - 17-Oct-2005- Agensys and Merck Announc e Agreement to Co-Develop and Commercialize a Novel Antibody for Cancer Therapy - 27-Sep-2005- Merck Expands...
Matching: Find similar documents More document info
100%
HTML
Merck: Corporate Responsibility: Policies and Performance
The Accelerating Access Initiative The Accelerating Access Initiative aims to help improve access to HIV/AIDS treatment.
Established in May 2000, it is a cooperative endeavor of UNAIDS, the World Health Organization, UNICEF, UNFPA, and the World Bank, and Merck and other research-based pharmaceutical companies.
Participants are committed to working with governments,...
Matching: efavirenz Find similar documents More document info
100%
HTML
Product review
Products 1 Aggrastat ® (tirofiban hydrochloride) •-In combination with heparin for treatment of acute coronary syndrome Arcoxia ® (etoricoxib) 2 •-Osteoarthritis •-Rheumatoid arthritis (in adults) •-Acute pain •-Chronic pain •-Dysmenorrhea (menstrual pain) •-Acute gouty arthritis Cancidas ® (caspofungin acetate) •...
Matching: efavirenz Find similar documents More document info
100%
HTML
LabCorp's Clinical Trials: What's New
AMC-IATEC AWARDS LABCORP TWO GLOBAL HIV STUDIES BURLINGTON, N.C., March 30, 2001 –The Academic Medical Centre –International Antiviral Therapy Evaluation Centre (AMC-IATEC), Amsterdam, The Netherlands, has selected the clinical trials testing division of Laboratory Corporation of America® Holdings (LabCorp®; NYSE: LH) for two global studies involving HIV-positive...
Matching: efavirenz Find similar documents More document info
100%
HTML
Hemispherx Biopharma, Inc. -- Research & Development: Clinical Trials: Chronic Fatigue Syndrome (CFS) : AMP 720
Home - | - Corporate Info - | - R & D - | - Products - | - Investor Relations - | - For the Patient - | - Careers at Hemispherx - - Should I Volunteer?
Efavirenz (Sustiva) 2.
Zalcitabine (Hivid) ddC 8.
Nelfinavir (Viracept) 5.
2 Combivir counts for one of the required anti-retroviral drugs.
Following eight (8) weeks of Ampligen® or No Ampligen®, HAART...
Matching: efavirenz Find similar documents More document info
100%
HTML
Hemispherx Biopharma, Inc. -- For The Patient- Clinical Trials: Chronic Fatigue Syndrome (CFS) : AMP 720
Home - | - Corporate Info - | - R & D - | - Products - | - Investor Relations - | - For the Patient - | - Careers at Hemispherx - - Should I Volunteer?
Efavirenz (Sustiva) 2.
Zalcitabine (Hivid) ddC 8.
2 Combivir counts for one of the required anti-retroviral drugs.
Eight (8) weeks after the plasma HIV RNA becomes undetectable, a second STI will be introduced and...
Matching: efavirenz Find similar documents More document info
100%
HTML
Human Immunodeficiency Virus Infection: Merck Manual Home Edition
Drugs For HIV Infection Type Drug Side Effects Non-nucleoside reverse transcriptase inhibitors - Delavirdine Rash, headaches - Efavirenz Dizziness, sleepiness, nightmares, confusion, agitation, forgetfulness, euphoria, rash - Nevirapine Rash (occasionally severe or life threatening), liver dysfunction Nucleoside and nucleotide reverse transcriptase inhibitors - - All may cause...
Matching: efavirenz Find similar documents More document info
100%
HTML
Human Immunodeficiency Virus (HIV) Infection - Quest Diagnostics Patient Health Library
Human Immunodeficiency Virus (HIV) Infection Medications Drugs are the primary treatment for HIV.
However, over the past few years this routine has become much simpler and many people take a cocktail only once or twice a day.
Using HAART reduces your risk of developing drug resistance.
Drug side effects and your willingness to tolerate them.
Medication Choices...
Matching: efavirenz Find similar documents More document info
100%
HTML
Human Immunodeficiency Virus (HIV) Infection - Quest Diagnostics Patient Health Library
Human Immunodeficiency Virus (HIV) Infection Treatment Overview The most effective treatment for HIV is highly active antiretroviral therapy (HAART) —a combination of several antiretroviral drugs that aims to control the amount of virus in your body.
Nonnucleoside reverse transcriptase inhibitors (NNRTIs) , such as efavirenz, nevirapine, or delavirdine.
Benefits.
Matching: efavirenz Find similar documents More document info
100%
HTML
Protease inhibitors (PIs) for HIV - [Medication] - Quest Diagnostics Patient Health Library
Protease inhibitors (PIs) for HIV Examples Brand Name Chemical Name Fortovase, Invirase saquinavir Norvir ritonavir Crixivan indinavir Viracept nelfinavir Kaletra lopinavir and ritonavir Reyataz atazanavir Lexiva fosamprenavir Atazanavir (Reyataz) and fosamprenavir (Lexiva) are new protease inhibitors that were recently approved by the U.S.
The preferred combination is 2...
Matching: efavirenz Find similar documents More document info
100%
HTML
Nucleoside reverse transcriptase inhibitors (NRTIs) for HIV - [Medication] - Quest Diagnostics Patient Health Library
Nucleoside reverse transcriptase inhibitors (NRTIs) for HIV Examples Brand Name Chemical Name Ziagen abacavir Videx didanosine, also known as dideoxyinosine, ddI 3TC, Epivir lamivudine Zerit stavudine (d4T) Hivid zalcitabine, also known as dideoxycytidine, ddC Retrovir zidovudine (ZDV), formerly known as azidothymidine (AZT) Trizivir abacavir, zidovudine, and lamivudine Epzicom...
Matching: efavirenz Find similar documents More document info
100%
HTML
Nonnucleoside reverse transcriptase inhibitors (NNRTIs) for HIV - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Nonnucleoside reverse transcriptase inhibitors (NNRTIs) for HIV - [Medication] - Quest Diagnostics Patient Health Library Nonnucleoside reverse transcriptase inhibitors (NNRTIs) for HIV - [Medication] - Quest Diagnostics Patient Health Library Immune system,...
Matching: efavirenz Find similar documents More document info
100%
HTML
Patricia M. Flynn, MD
In order for our site to display correctly you will need a newer version of your web browser.
Jude News Donate Now Contact Us Shop En Espanol Patients & Parents Clinical Science Basic Science Referring MDs Careers International Volunteers Ways to Help Hematologic Malignancies Faculty - Home - Basic Science Home - Multidisciplinary Programs and Centers - Hematologic Malignancies...
author: St. Jude Children's Research Hospital
Matching: efavirenz Find similar documents More document info
100%
HTML
Patricia M. Flynn, MD
In order for our site to display correctly you will need a newer version of your web browser.
Jude News Donate Now Contact Us Shop En Espanol Patients & Parents Clinical Science Basic Science Referring MDs Careers International Volunteers Ways to Help Infection and Host Defense Faculty - Home - Basic Science Home - Infection & Host Defense - Infection and Host Defense Faculty -...
author: St. Jude Children's Research Hospital
Matching: efavirenz Find similar documents More document info
100%
HTML
Patricia M. Flynn, MD
In order for our site to display correctly you will need a newer version of your web browser.
Jude News Donate Now Contact Us Shop En Espanol Patients & Parents Clinical Science Basic Science Referring MDs Careers International Volunteers Ways to Help Children's Infection Defense Center (CIDC) Faculty Bacterial Pathogenesis Faculty HIV Therapeutics & Vaccine Development Faculty...
author: St. Jude Children's Research Hospital
Matching: efavirenz Find similar documents More document info
100%
HTML
A to Z List - Medication Information
Jude Children's Research Hospital.- Disclaimer / Registrations / Copyright Statement - Privacy Policy - Notice of Privacy Practices - Linking Policy - Help A to Z List - Medication Information A to Z List - Medication Information abacavir, lamivudine, zidovudine, trizivir, acyclovir, allopurinol, amifostine, amitriptyline, amlodipine, amoxicillin, clavulanic_acid, augmentin,...
author: St. Jude Children's Research Hospital
Matching: efavirenz Find similar documents More document info
100%
HTML
HIV Protocols / Clinical Studies
In order for our site to display correctly you will need a newer version of your web browser.
Opera v7 or higher (Windows, Linux) Apple's Safari (Mac OS X) Konqueror (Linux KDE Desktop) Microsoft Internet Explorer v6 or higher (Windows) or v5 or higher (Macintosh) Please note that this is not intended be an exhaustive list of browsers that support web standards, nor a test of...
author: St. Jude Children's Research Hospital
Matching: Find similar documents More document info

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.